Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL

Free Radical Biology and Medicine

Volumn 23, Issue 1, 1997, Pages 34-46

  Fuhrman, Bianca ^a   Judith, Oiknine ^a   Keidar, Shlomo ^a   Ben Yaish, Limor ^a   Kaplan, Marielle ^a   Aviram, Michael ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

LDL oxidation; LDL receptor; Macrophages

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN; CHOLESTEROL; DEOXYCHOLIC ACID; FERROUS SULFATE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BINDING KINETICS; CELL FRACTIONATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; INCUBATION TIME; LIPID PEROXIDATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RECEPTOR UPREGULATION;

ANGIOTENSIN II; ANIMALS; CELL LINE; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; DEOXYCHOLIC ACID; ELECTROPHORESIS, CELLULOSE ACETATE; FERROUS COMPOUNDS; HEPARIN; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; OXIDANTS; OXIDATION-REDUCTION; RECEPTORS, LDL; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

ANIMALIA;

EID: 0031011549     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00588-6     Document Type: Article

References (70)

1. Brown M. S., Goldstein J. L. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52:1983;223-261.
2. Aviram M. Effect of lipoproteins and platelets on macrophage cholesterol metabolism. Harris T. R. Blood cell biochemistry. Megakaryocytes, platelets, macrophages and eosinophils. 2:1991;179-208 Plenum Publishing Corporation, New York.
3. Aviram M. Modified forms of low density lipoprotein and atherogenesis. Atherosclerosis. 8:1993;1-9.
4. Aviram M., Maor I. Phospholipase D-modified low density lipoprotein is taken up by macrophages at increased rate: A possible role for phosphatidic acid. J. Clin. Invest. 91:1993;1942-1952.
5. Aviram M. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells. J. Biol. Chem. 267:1992;218-225.
6. Aviram M., Bierman E. L., Chait A. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J. Biol. Chem. 263:1988;15416-15422.
7. Aviram M., Lund-Katz S., Phillips M. C., Chait A. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J. Biol. Chem. 263:1988;16842-16848.
8. 2-modified LDL is taken up at enhanced rate by macrophages. Biochem. Biophys. Res. Commun. 185:1992;465 - 743.
9. Kleinman Y., Krul E. S., Brunes M., Aronson W., Pfleger B., Schonfeld G. Lipolysis of LDL with phospholipase A alters the expression of selected apo B-100 epitopes and the interaction of LDL with cells. J. Lipid Res. 29:1988;729-743.
10. Oiknine J., Aviram M. Increased susceptibility to activation and increased uptake of LDL by cholesterol loaded macrophages. Arterioscler. Thromb. 12:1992;745-753.
11. Suits A. G., Chait A., Aviram M., Heinecke J. W. Phagocytosis of aggregated lipoprotein by macrophages: Role of the low density lipoprotein receptor in foam cell formation. Proc. Natl. Acad. Sci. USA. 86:1989;2713-2717.
12. Heinecke J. W., Suits A. G., Aviram M., Chait A. Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Arterioscler. Thromb. 11:1991;1643-1651.
13. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
14. Aviram M. Beyond cholesterol: Modification of lipoproteins and increased atherogenicity. Gensini G. G., Abbate R., Prisco D. Atherosclerosis, inflammation and thrombosis Neri Serneri. 1993;15-36 Scientific Press, Florence.
15. Parthasarathy S., Printz D. J., Boyd D., Joy L., Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 6:1986;505-510.
16. Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein and atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
17. Steinbrecher U. P., Zhang H., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med. 9:1990;155-168.
18. Palinksi W., Rosenfeld M. E., Yla-Herttuala S., Gutner G. C., Socher S. S., Buttler S. W., Parthasarathy S., Carew T. E., Steinberg D., Witztum J. L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
19. Yla-Herttuala S., Rosenfeld M. E., Parthasarathy S., Sigal E., Sarkioja T., Witztum J. L., Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid protein adducts. J. Clin. Invest. 87:1991;1146-1152.
20. Yla-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Buttler S., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
21. Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
22. Heinecke, J. W.; Rosen, H.; Chait, A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.J. Clin. Invest. 74:1980-1894; 1984.
23. Aviram M., Rosenblat M. Macrophage mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J. Lipid. Res. 35:1994;385-398.
24. Fuhrman B., Oiknine J., Aviram M. Iron induces lipid peroxidation in cultured macrophages increases their ability to oxidatively modify LDL and affects their secretory properties. Atherosclerosis. 111:1994;65-78.
25. Keidar S., Kaplan M., Hoffman A., Aviram M. Angiotensin II stimulated macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis. 115:1995;201-215.
26. Delzenne N. M., Calderon P. B., Taper H. S., Roberfroid M. D. Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: In vivo and in vitro studies. Toxicol Lett. 61:1992;291-304.
27. Ljubuncic P., Fuhrman B., Oiknine J., Aviram M., Bomzon A. The effect of decoxycholic acid and ursodeoxycholic acid on lipid peroixdation in cultured macrophages. Gut. 39:1996;475-478.
28. Leake D. S. Effects of mildly oxidized low density lipoprotein on endothelial cell function. Curr. Opin. Lipidol. 2:1991;301-305.
29. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Bamshad B., Esterson M., Fogelman A. M. Minimally modified low density lipoprotein stimulates monocyte endothelial interaction. J. Clin. Invest. 85:1990;1260-1266.
30. Zhang H. F., Davis W. B., Chen X. S., Jone K. H., Whisler R. L., Cornwell D. G. The effects of oxidized low density lipoproteins on arachidonic acid metabolism in smooth muscle cells. J. Lipid Res. 31:1990;551-565.
31. Haberland M. E., Fogelman A. M., Edwards P. A. Specificity of receptor mediated recognition of malondialdehyde modified low density lipoproteins. Proc. Natl. Acad. Sci. USA. 79:1982;1712-1716.
32. Buege J. A., Aust S. D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
33. El-Saadani M., Esterbauer M., El-Sayed M., Goher M., Nassar A. Y., Jurgens J. A spectrophotometric assay of lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:1989;627.
34. Patterson M. K. J. Measurement of growth and viability of cells in culture. Methods Enzymol. 58:1979;141.
35. 3H-adenine and lactate dehydrogenase. J. Lab. Clin. Med. 106:1985;253.
36. Aviram M. Plasma lipoprotein separation by discontinous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30:1983;111-118.
37. Bilheimer D. W., Eisenberg S., Levy R. I. The metabolism of very low density lipoproteins. Biochim. Biophys. Acta. 260:1972;212-221.
38. Colf B., VerHeyden J. Electrophoresis and sudan black staining of lipoproteins on gelatinized cellulose acetate. Clin. Chim. Acta. 18:1967;325-334.
39. Steinbrecher U. P., Witztum J. L., Parthasarathy S., Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor mediated catabolism. Arteriosclerosis. 7:1987;135-143.
40. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
41. Bierman E. L., Stein O., Stein Y. Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture. Circ. Res. 35:1974;136-150.
42. Chiamori N., Henry R. J. Study of the ferric chloride method for determination of total cholesterol and cholesterol esters. Am. J. Clin. Pathol. 31:1959;305-309.
43. Keidar S., Goldberg A. C., Cook K., Bateman J., Schonfeld G. A high carbohydrate-fat free diet alters the proportion of heparin bound VLDL in plasma and expression of VLDL-apo-B-100 epitopes. Metab. Clin. Exp. 39:1990;281-288.
44. Witztum J. L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
45. Berliner Y. A., Navab M., Fogelman A. M., Frank J. S., Demer L. L., Edwards P. A., Watson A. D., Lusis A. J. Atherosclerosis: Basic mechanisms, oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
46. Parthasarathy S. Mechanism(s) of cell-mediated oxidation of low density lipoprotein. Nohl H., Esterbauer H., Rice Evans C. Free radicals in the environment, medicine and toxicology. 1994;163-179 Richelieu Press, London, UK.
47. Salonen J. T. The role of iron as a cardiovascular risk factor. Curr. Opin. Lipidol. 4:1993;277-283.
48. Kiechl S., Aichner F., Gerstenbrand F., Egger G., Mair A., Rungger G., Spogler F., Jarosch E., Oberhollenzer F., Willeit J. Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck study. Arterioscler. Thromb. 14:1994;1625-1630.
49. Keidar S., Kaplan M., Shapira H., Brook J. G., Aviram M. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: A possible role for angiotensin II. Atherosclerosis. 104:1994;71-84.
50. Dzau V. J. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation. 77:1988;14.
51. Sokol R. J., Devereaux M., Khandwala R., O'Brien K. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology. 17:1993;869-881.
52. Poupon R. E., Chretien Y., Poupon R., Paumgartner G. Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy. Hepatology. 17:1993;599-604.
53. McNally A. K., Chisolm G. M., Morel D. W., Cathcart M. K. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. J. Immunol. 145:(1):1990;254-259.
54. Cathcart M. K., McNally A. K., Morel D. W., Chisolm G. M. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. J. Immunol. 142:(6):1989;1963-1969.
55. Scaccini C., Jialal I. LDL modification by activated polymorphonuclear leukocytes: A cellular model of mild oxidative stress. Free. Radic. Biol. Med. 16:1994;49-55.
56. Wheeler D. C., Chana R. S., Topley N., Pertersen M. M., Davies M., Williams J. D. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int. 45:1994;1628-1636.
57. Keidar S., Brook J. G., Rosenblat M., Fuhrman B., Dankner G., Aviram M. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein. Arterioscler. Thromb. 12:1992;484-493.
58. Haberland M. E., Olch C. L., Fogelman A. M. Roles of lysines in mediating interaction of modified low density lipoprotein with the scavenger receptor of human monocyte macrophages. J. Biol. Chem. 259 (18):1984;11305-11311.
59. Hirose N., Blankenship D. T., Krivanek M. A., Jackson R. L., Cardin A. D. Isolation and characterization of LDL by heparin-binding cyanogen bromide peptides of human plasma apolipoprotein B. Biochemistry. 26:1987;5505-5512.
60. McLean L. R., Haegeman K. A. Effect of probucol on the physical properties of low density lipoprotein oxidized by copper. Biochemistry. 28:1989;321-327.
61. de Graaf J., Hak-Lemmers H. L. M., Hectors M. P. C., Demacker P. N. M., Hendriks J. C. M., Stalenhoef A. F. H. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler. Thromb. 11:1991;298-306.
62. Tribble D. L., Holl L. G., Wood P. D., Krauss R. M. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 83:1992;189-199.
63. Shimano H., Yamada N., Ishibashi S., Mokuno H., Mori N., Gotoda T., Harada K., Akamuma Y., Murase T., Yazaki Y., Takaku F. Oxidation-labile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography. J. Lipid. Res. 32:1991;763-773.
64. de Graaf J., Hendriks J. C. M., Demacker P. N. M., Falenhoef A. F. H. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment. Arterioscler. Thromb. 13:1993;712-719.
65. Avogaro P., Bon G. B., Cazzolato G. Presence of a modified low density lipoprotein in human. Arteriosclerosis. 8:1988;79-87.
66. Tabas I., Welland D. A., Tall A. R. Unmodified low density lipoprotein causes cholesteryl ester accumulation in J-774 macrophages. Proc. Natl. Acad. Sci. USA. 82:1985;416-420.
67. Elsworth J. L., Chandrasekaran C., Cooper D. A. Evidence for sterol-independent regulation of low density lipoprotein receptor activity in Hep-G2 cells. Biochem. J. 279:1991;175-187.
68. Grove R. I., Mazzucco C. E., Radka S. F., Shoyab M., Kiener P. A. Oncostatin M up-regulates low density lipoprotein receptors in Hep-G2 cells by a novel mechanism. J. Biol. Chem. 266:1991;18194-18199.
69. Middleton B., Middleton A. Cyclic AMP stimulates the synthesis and function of the low density lipoprotein receptor in human vascular smooth muscle cells and fibroblasts. Biochem. J. 282:1992;853-861.
70. Lopes-Virella M. F., Klein R. L., Stevenson H. C. Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products. Arteriosclerosis. 7:1987;176-184.